eli lilly lawsuit tirzepatide FDA approves tirzepatide, Lilly's new type 2 diabetes drug, and the company shares an estimated price Mounjaro Lawsuit - July 2026

The first STEP trial (a series of large clinical trials that investigated who semaglutide helps and in what context) reported a 14.9% reduction in body weight over 72 weeks for participants taking 2.4 mg weekly

The starting dose of 0.25 mg is gradually increased over several weeks

Find enjoyable ways to stay active

Wegovy is approved for weight management at a higher maximum dose

Semaglutide Important Safety Information Regarding Compounded Semaglutide Products Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products

GLP-1 based therapies: differential effects on fasting and postprandial glucose